Evidence map›Paper›PMID 41867350›Full record

ArticleThe annals of applied statistics2026

DYNAMIC CLASSIFICATION OF LATENT DISEASE PROGRESSION WITH AUXILIARY SURROGATE LABELS.

Zexi Cai, Donglin Zeng, Karen S Marder, Lawrence S Honig, Yuanjia Wang

Abstract read
In one paragraph

Article in The annals of applied statistics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zexi CaiDepartment of Biostatistics, Columbia University, New York, USA.ORCID 0000-0002-0253-8045
Donglin ZengDepartment of Biostatistics, University of Michigan, Ann Arbor, USA.ORCID 0000-0003-0843-9280
Karen S MarderDepartment of Psychiatry, Columbia University Medical Center, New York, USA.
Lawrence S HonigDepartment of Psychiatry, Columbia University Medical Center, New York, USA.ORCID 0000-0002-9703-2265
Yuanjia WangDepartment of Biostatistics, Columbia University, New York, USA.ORCID 0000-0002-1510-3315

Funding

Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
National Alzheimer's Coordinating CenterU24AG072122 · NIA · UNIVERSITY OF WASHINGTON · PI STEPHENS, KARI A · 2021 to 2025
$45.8M
Targeting Lewy Body Specific Pathology Using BiomarkersU01NS100600 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HONIG, LAWRENCE S, MARDER, KAREN S · 2016 to 2020
$4.5M
Statistical Methods for Integrating Mixed-type Biomarkers and Phenotypes in Neurodegenerative Disease ModelingR01NS073671 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, YUANJIA · 2011 to 2025
$3.9M
Statistical and Machine Learning Methods to Improve Dynamic Treatment Regimens Estimation Using Real World Data.R01GM124104 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Yuanjia Wang, Donglin Zeng · 2018 to 2026
$3.1M
Machine Learning Methods for Optimizing Individualized Treatment Strategies for Precision PsychiatryR01MH123487 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, YUANJIA · 2021 to 2025
$2.0M
NCATS NIH HHS UL1 TR001873NIA NIH HHS U24 AG072122NIGMS NIH HHS R01 GM124104NIMH NIH HHS R01 MH123487NINDS NIH HHS R01 NS073671NINDS NIH HHS U01 NS100600
6 · The paper itself

Abstract

Disease progression prediction based on patients' evolving health information is challenging when true disease states are unknown due to diagnostic capabilities or high costs. For example, the absence of gold-standard neurological diagnoses hinders distinguishing Alzheimer's disease (AD) from related conditions such as AD-related dementias (ADRDs), including Lewy body dementia (LBD). Combining temporally dependent surrogate labels and health markers may improve disease prediction. However, existing literature models informative surrogate labels and observed variables that reflect the underlying states using purely generative approaches, often posing unrealistic assumptions on the outcomes and suffering from misspecification thereof. We propose integrating the conventional hidden Markov model as a generative model with a time-varying discriminative classification model to simultaneously handle potentially misspecified surrogate labels and incorporate important markers of disease progression. We develop an adaptive forward-backward algorithm with subjective labels for estimation, and utilize the modified posterior and Viterbi algorithms to predict the progression of future states or new patients based on objective markers only. Importantly, the adaptation eliminates the need to model the marginal distribution of longitudinal markers, a requirement in traditional algorithms. Asymptotic properties are established, and significant improvements in finite samples are demonstrated via simulation studies. Analysis of the neuropathological dataset of the National Alzheimer's Coordinating Center (NACC) shows much improved accuracy in distinguishing LBD from AD.

Indexed as

Alzheimer’s diseaseDisease progressionGenerative-Discriminative modelHidden Markov modelLatent states

Identifiers

PMID41867350
PMCPMC13004507

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.